PMDA drug package insert
長城甦腎宝錠A
PMDA OTC drug · 日邦薬品工業（株） · package insert Jan 17, 2026
Key facts
| Brand names | 長城甦腎宝錠A |
|---|---|
| Companies | 製造販売元／アスゲン製薬（株）,販売元／日邦薬品工業（株） |
| Product type | OTC drug |
| OTC risk class | 第２類医薬品 |
| OTC dosage form | 錠剤 |
| OTC effect category | ビタミン含有保健薬（ビタミン剤等） |
| Package insert date | Jan 17, 2026 |
| PMDA document key | 100122_J2501000161 |
| PMDA company code | 100122 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: